27 employees
Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
2006
$2.2M
from 1 investors over 1 rounds
Laminar Pharma raised $2.2M on September 1, 2019
Investors: Capital Cell